Literature DB >> 34510457

Phenotyping heart failure using model-based analysis and physiology-informed machine learning.

Edith Jones1, E Benjamin Randall1, Scott L Hummel2,3, David M Cameron4, Daniel A Beard1, Brian E Carlson1.   

Abstract

To phenotype mechanistic differences between heart failure with reduced (HFrEF) and preserved (HFpEF) ejection fraction, a closed-loop model of the cardiovascular system coupled with patient-specific transthoracic echocardiography (TTE) and right heart catheterization (RHC) data was used to identify key parameters representing haemodynamics. Thirty-one patient records (10 HFrEF, 21 HFpEF) were obtained from the Cardiovascular Health Improvement Project database at the University of Michigan. Model simulations were tuned to match RHC and TTE pressure, volume, and cardiac output measurements in each patient. The underlying physiological model parameters were plotted against model-based norms and compared between HFrEF and HFpEF. Our results confirm the main mechanistic parameter driving HFrEF is reduced left ventricular (LV) contractility, whereas HFpEF exhibits a heterogeneous phenotype. Conducting principal component analysis, k -means clustering, and hierarchical clustering on the optimized parameters reveal (i) a group of HFrEF-like HFpEF patients (HFpEF1), (ii) a classic HFpEF group (HFpEF2), and (iii) a group of HFpEF patients that do not consistently cluster (NCC). These subgroups cannot be distinguished from the clinical data alone. Increased LV active contractility ( p < 0.001 ) and LV passive stiffness ( p < 0.001 ) at rest are observed when comparing HFpEF2 to HFpEF1. Analysing the clinical data of each subgroup reveals that elevated systolic and diastolic LV volumes seen in both HFrEF and HFpEF1 may be used as a biomarker to identify HFrEF-like HFpEF patients. These results suggest that modelling of the cardiovascular system and optimizing to standard clinical data can designate subgroups of HFpEF as separate phenotypes, possibly elucidating patient-specific treatment strategies. KEY POINTS: Analysis of data from right heart catheterization (RHC) and transthoracic echocardiography (TTE) of heart failure (HF) patients using a closed-loop model of the cardiovascular system identifies key parameters representing haemodynamic cardiovascular function in patients with heart failure with reduced and preserved ejection fraction (HFrEF and HFpEF). Analysing optimized parameters representing cardiovascular function using machine learning shows mechanistic differences between HFpEF groups that are not seen analysing clinical data alone. HFpEF groups presented here can be subdivided into three subgroups: HFpEF1 described as 'HFrEF-like HFpEF', HFpEF2 as 'classic HFpEF', and a third group of HFpEF patients that do not consistently cluster. Focusing purely on cardiac function consistently captures the underlying dysfunction in HFrEF, whereas HFpEF is better characterized by dysfunction in the entire cardiovascular system. Our methodology reveals that elevated left ventricular systolic and diastolic volumes are potential biomarkers for identifying HFrEF-like HFpEF patients.
© 2021 The Authors. The Journal of Physiology © 2021 The Physiological Society.

Entities:  

Keywords:  zzm321990 zzm321990 kzzm321990 zzm321990-means clustering; cardiovascular systems modelling; clinical data; hierarchical clustering; preserved ejection fraction; reduced ejection fraction

Mesh:

Year:  2021        PMID: 34510457      PMCID: PMC8595692          DOI: 10.1113/JP281845

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  35 in total

1.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  Circulation       Date:  2013-06-05       Impact factor: 29.690

2.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Monica M Colvin; Mark H Drazner; Gerasimos S Filippatos; Gregg C Fonarow; Michael M Givertz; Steven M Hollenberg; JoAnn Lindenfeld; Frederick A Masoudi; Patrick E McBride; Pamela N Peterson; Lynne Warner Stevenson; Cheryl Westlake
Journal:  J Am Coll Cardiol       Date:  2017-04-28       Impact factor: 24.094

3.  Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone.

Authors:  Jordana B Cohen; Sarah J Schrauben; Lei Zhao; Michael D Basso; Mary Ellen Cvijic; Zhuyin Li; Melissa Yarde; Zhaoqing Wang; Priyanka T Bhattacharya; Diana A Chirinos; Stuart Prenner; Payman Zamani; Dietmar A Seiffert; Bruce D Car; David A Gordon; Kenneth Margulies; Thomas Cappola; Julio A Chirinos
Journal:  JACC Heart Fail       Date:  2020-01-08       Impact factor: 12.035

Review 4.  Leveraging Signaling Pathways to Treat Heart Failure With Reduced Ejection Fraction.

Authors:  Miguel Pinilla-Vera; Virginia S Hahn; David A Kass
Journal:  Circ Res       Date:  2019-05-24       Impact factor: 17.367

5.  Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database.

Authors:  Clyde W Yancy; Margarita Lopatin; Lynne Warner Stevenson; Teresa De Marco; Gregg C Fonarow
Journal:  J Am Coll Cardiol       Date:  2005-12-15       Impact factor: 24.094

6.  Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction.

Authors:  Margaret M Redfield; Kevin J Anstrom; James A Levine; Gabe A Koepp; Barry A Borlaug; Horng H Chen; Martin M LeWinter; Susan M Joseph; Sanjiv J Shah; Marc J Semigran; G Michael Felker; Robert T Cole; Gordon R Reeves; Ryan J Tedford; W H Wilson Tang; Steven E McNulty; Eric J Velazquez; Monica R Shah; Eugene Braunwald
Journal:  N Engl J Med       Date:  2015-11-08       Impact factor: 91.245

7.  20th Annual Feigenbaum Lecture: Echocardiography for Precision Medicine-Digital Biopsy to Deconstruct Biology.

Authors:  Sanjiv J Shah
Journal:  J Am Soc Echocardiogr       Date:  2019-11       Impact factor: 5.251

8.  Deep phenotyping of cardiac function in heart transplant patients using cardiovascular system models.

Authors:  Amanda L Colunga; Karam G Kim; N Payton Woodall; Todd F Dardas; John H Gennari; Mette S Olufsen; Brian E Carlson
Journal:  J Physiol       Date:  2020-06-23       Impact factor: 5.182

Review 9.  Role of Volume Redistribution in the Congestion of Heart Failure.

Authors:  Marat Fudim; Adrian F Hernandez; G Michael Felker
Journal:  J Am Heart Assoc       Date:  2017-08-17       Impact factor: 5.501

10.  The 'Digital Twin' to enable the vision of precision cardiology.

Authors:  Jorge Corral-Acero; Francesca Margara; Maciej Marciniak; Cristobal Rodero; Filip Loncaric; Yingjing Feng; Andrew Gilbert; Joao F Fernandes; Hassaan A Bukhari; Ali Wajdan; Manuel Villegas Martinez; Mariana Sousa Santos; Mehrdad Shamohammdi; Hongxing Luo; Philip Westphal; Paul Leeson; Paolo DiAchille; Viatcheslav Gurev; Manuel Mayr; Liesbet Geris; Pras Pathmanathan; Tina Morrison; Richard Cornelussen; Frits Prinzen; Tammo Delhaas; Ada Doltra; Marta Sitges; Edward J Vigmond; Ernesto Zacur; Vicente Grau; Blanca Rodriguez; Espen W Remme; Steven Niederer; Peter Mortier; Kristin McLeod; Mark Potse; Esther Pueyo; Alfonso Bueno-Orovio; Pablo Lamata
Journal:  Eur Heart J       Date:  2020-12-21       Impact factor: 29.983

View more
  1 in total

1.  Heart Failure as a Limitation of Cardiac Power Output.

Authors:  Daniel A Beard; Scott L Hummel; Filip Jezek
Journal:  Function (Oxf)       Date:  2021-12-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.